MPO and cancer: Tyrosine modified by ROS and RNS can serve as a stable oxidative stress marker, a prognostic marker in cancer [17], and as an indicator of NOS2, MPO, or EPO activity [15] and therefore a marker of inflammatory leukocyte-mediated tissue damage [18].